Literature DB >> 31598110

Ototoxicity and Nephrotoxicity With Elevated Serum Concentrations Following Vancomycin Overdose: A Retrospective Case Series.

Kazuhiro Uda, Junichi Suwa, Kenta Ito, Hiroshi Hataya, Yuho Horikoshi.   

Abstract

Although a high vancomycin serum concentration is known to be associated with nephrotoxicity, its association with ototoxicity is not well known. The purpose of our study was to examine the latter association in pediatric patients, especially in cases of accidental overdose. Pediatric patients who received vancomycin at our facility between March 2010 and December 2015 with a serum trough concentration > 30 mg/L were enrolled. Age, sex, neonatal hearing screening results, estimated peak vancomycin serum concentration, duration of drug exposure, renal function, and hearing test results were collected. The estimated duration of concentrations above 30 or 80 mg/L were simulated with the Sawchuk-Zaske method. We defined a "high concentration" and "toxic concentration" of vancomycin as 30 to 80 mg/L and > 80 mg/L, respectively. Ototoxicity was assessed based on the auditory brain stem response. We identified 4 females and 2 males with normal hearing at birth. Four of the 6 patients were ≤ 3 months old. All the patients reached an estimated peak serum concentration of > 80 mg/L, and 5 exceeded 150 mg/L. The estimated duration of exposure to a high concentration and toxic concentration of vancomycin was 15 to 62 hours and 8 to 43 hours, respectively. All the patients experienced transient renal dysfunction. Although transient ototoxicity was found in 1 patient, prolonged ototoxicity was not observed in any of the patients. All the patients had received an accidental overdose of vancomycin. Prolonged hearing loss due to a high vancomycin serum concentration was not found in any of the subjects in the present report. Copyright Published by the Pediatric Pharmacy Advocacy Group. All rights reserved. For permissions, email: matthew.helms@ppag.org 2019.

Entities:  

Keywords:  child; deafness; neonate; nephrotoxicity; ototoxicity; overdose; vancomycin

Year:  2019        PMID: 31598110      PMCID: PMC6782114          DOI: 10.5863/1551-6776-24.5.450

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  23 in total

1.  Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report.

Authors:  J E GERACI; F R HEILMAN; D R NICHOLS; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1958-04-02

Review 2.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 3.  Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise.

Authors:  E Zimmerman; A Lahav
Journal:  J Perinatol       Date:  2012-08-09       Impact factor: 2.521

Review 4.  Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

Authors:  Matthew James; Josée Bouchard; Julie Ho; Scott Klarenbach; Jean-Phillipe LaFrance; Claudio Rigatto; Ron Wald; Michael Zappitelli; Neesh Pannu
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

5.  Factors associated with acute kidney injury in children receiving vancomycin.

Authors:  Elizabeth A Sinclair; Gayane Yenokyan; Andrea McMunn; Jeffrey J Fadrowski; Aaron M Milstone; Carlton K K Lee
Journal:  Ann Pharmacother       Date:  2014-09-03       Impact factor: 3.154

Review 6.  Vancomycin ototoxicity and nephrotoxicity. A review.

Authors:  G R Bailie; D Neal
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 7.  Global problem of drug-induced hearing loss.

Authors:  E Arslan; E Orzan; R Santarelli
Journal:  Ann N Y Acad Sci       Date:  1999-11-28       Impact factor: 5.691

8.  Large vancomycin overdose in two premature infants with minimal toxicity.

Authors:  Lonnie J Miner; Roger G Faix
Journal:  Am J Perinatol       Date:  2004-11       Impact factor: 1.862

9.  Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs.

Authors:  R E Brummett; K E Fox; F Jacobs; J B Kempton; Z Stokes; A B Richmond
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-01

10.  Vancomycin ototoxicity: a reevaluation in an era of increasing doses.

Authors:  Avisheh Forouzesh; Pamela A Moise; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.